Sanofi Profit Dips on Generic Competition, Pandemic Flu End
Sanofi-Aventis SA, the French drugmaker that bought Genzyme Corp. this month, said first- quarter profit fell as generic competition dented sales of five key medicines and the end of the pandemic wiped out demand for swine flu vaccines.
